Medical technology company Carl Zeiss Meditec AG (CZMWF.PK) reported Friday that its fiscal 2016 earnings per share climbed to 1.21 euros from last year's 0.77 euro.
Earnings before interest and taxes or EBIT rose to 154.3 million euros from 130.6 million euros a year ago. The EBIT margin increased to 14.2 percent from prior year's 12.6 percent.
Revenue increased 4.6 percent year-over-year to 1.09 billion euros. Adjusted for currency effects, revenues increased 2.7 percent.
Revenue in the Ophthalmic Systems unit increased 7.5 percent, Surgical Ophthalmology revenue grew 4.3 percent. The combined SBU Ophthalmic Devices would have grown revenue by 6 percent. Revenue growth in the Microsurgery SBU was 1.3 percent.
Asia/Pacific revenue climbed 19.5 percent, mainly attributable to the Chinese market, as well as Southeast Asia and South Korea.
Revenue in the EMEA region declined 1.7 percent and in the Americas region decreased 2.2 percent.
Looking ahead, Carl Zeiss Meditec expects to continue growing at least the same rate as the underlying market in fiscal year 2016/17. The EBIT margin is expected to continue to move within the range also forecast for the medium term, of 13-15%.
For comments and feedback: editorial@rttnews.com